Zeya Health

Apex Health Systems Pte. Ltd. , doing business as Zeya Health, based in Singapore, develops an AI-driven virtual front desk system that enhances operational efficiency for healthcare clinics by automating administrative tasks. Zeya Health specializes in providing AI solutions to streamline administrative workflows in healthcare.

The company was founded in Singapore in 2025. In January 2026, Zeya Health raised USD 575,000 in pre-seed funding led by Antler. Zeya Health's primary offering is an AI-driven virtual front desk designed to streamline administrative workflows for healthcare clinics. This solution automates tasks such as patient reminders, appointment bookings, rescheduling, follow-ups, and insurance checks, effectively allowing clinics to operate with reduced administrative burden.

By integrating with existing Electronic Health Record (EHR) systems and communication platforms like WhatsApp, Zeya Health enables clinics to maintain their operational routines while enhancing efficiency. The product is tailored for medical facilities, including private clinics and healthcare providers, facilitating smoother patient engagement and reducing no-show rates. Zeya Health's services are primarily available in Southeast Asia, focusing on markets such as Singapore and Malaysia, catering to a diverse client base that includes various healthcare professionals and institutions. Zeya Health generates revenue through a subscription model, providing clinics access to its automated front desk solutions.

The company's transactional structure involves direct partnerships with healthcare providers, allowing them to seamlessly integrate Zeya’s services into their existing workflows without the need for extensive training. Clients typically subscribe to a tiered service plan that aligns with their specific operational requirements, which may include options for additional features or support packages. The revenue model is designed to ensure that clinics realize a substantial return on investment by minimizing administrative workloads and enhancing patient management efficiency, positioning the company as a critical partner in the healthcare sector's ongoing digital transformation. The company plans to use the funding from January 2026 to develop its products and expand its healthcare solutions across the Asia‑Pacific region.